GC Cell Corporation (KOSDAQ:144510)
23,100
+250 (1.09%)
Apr 10, 2026, 3:30 PM KST
GC Cell Revenue
In the year 2025, GC Cell had annual revenue of 165.52B KRW, down -5.12%. GC Cell had revenue of 38.00B in the quarter ending December 31, 2025, a decrease of -10.82%.
Revenue
165.52B
Revenue Growth
-5.12%
P/S Ratio
2.10
Revenue / Employee
237.14M
Employees
698
Market Cap
347.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 165.52B | -8.93B | -5.12% |
| Dec 31, 2024 | 174.45B | -13.09B | -6.98% |
| Dec 31, 2023 | 187.54B | -48.58B | -20.57% |
| Dec 31, 2022 | 236.12B | 67.81B | 40.29% |
| Dec 31, 2021 | 168.31B | 82.75B | 96.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Cross Holdings | 2.45T |
| EASY BIO,Inc. | 476.94B |
| Bioneer | 330.11B |
| BINEX | 168.47B |
| JETEMA, | 76.90B |
| HLB Therapeutics | 69.56B |
| SillaJen | 9.23B |
| Anterogen.Co.,Ltd. | 7.54B |